Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Drlica

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Antimicrobial Chemotherapy|June 14, 2003
The mutant selection window and antimicrobial resistanceKarl Drlica
The Journal of Antimicrobial Chemotherapy|November 14, 2003
In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agentsTao Lu, Karl Drlica
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Fluoroquinolone-Gyrase-DNA Cleaved ComplexesGan Luan, Karl Drlica
Antimicrobial Agents and Chemotherapy|July 28, 2006
Moxifloxacin lethality against Mycobacterium tuberculosis in the presence and absence of chloramphenicolMuhammad Malik, Karl Drlica
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2007
Mutant selection window hypothesis updatedKarl Drlica, Xilin Zhao
The Journal of Antimicrobial Chemotherapy|June 12, 2008
A unified anti-mutant dosing strategyXilin Zhao, Karl Drlica
The Journal of Infectious Diseases|February 28, 2002
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection windowXilin Zhao, Karl Drlica
Current Topics in Medicinal Chemistry|February 7, 2003
Fluoroquinolones: action and resistanceKarl Drlica, Muhammad Malik
Current Opinion in Microbiology|August 1, 2014
Reactive oxygen species and the bacterial response to lethal stressXilin Zhao, Karl Drlica
Expert Review of Anti-Infective Therapy|October 21, 2020
Bacterial death from treatment with fluoroquinolones and other lethal stressorsKarl Drlica, Xilin Zhao
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Antimicrobial Chemotherapy|June 14, 2003
The mutant selection window and antimicrobial resistanceKarl Drlica
The Journal of Antimicrobial Chemotherapy|November 14, 2003
In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agentsTao Lu, Karl Drlica
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2017
Fluoroquinolone-Gyrase-DNA Cleaved ComplexesGan Luan, Karl Drlica
Antimicrobial Agents and Chemotherapy|July 28, 2006
Moxifloxacin lethality against Mycobacterium tuberculosis in the presence and absence of chloramphenicolMuhammad Malik, Karl Drlica
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2007
Mutant selection window hypothesis updatedKarl Drlica, Xilin Zhao
The Journal of Antimicrobial Chemotherapy|June 12, 2008
A unified anti-mutant dosing strategyXilin Zhao, Karl Drlica
The Journal of Infectious Diseases|February 28, 2002
Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection windowXilin Zhao, Karl Drlica
Current Topics in Medicinal Chemistry|February 7, 2003
Fluoroquinolones: action and resistanceKarl Drlica, Muhammad Malik
Current Opinion in Microbiology|August 1, 2014
Reactive oxygen species and the bacterial response to lethal stressXilin Zhao, Karl Drlica
Expert Review of Anti-Infective Therapy|October 21, 2020
Bacterial death from treatment with fluoroquinolones and other lethal stressorsKarl Drlica, Xilin Zhao
Pageof 10